Incidence and risk factors of immune reconstitution inflammatory syndrome in HIV-TB coinfected patients

Brazilian Journal of Infectious Diseases

Volumn 15, Issue 6, 2011, Pages 553-559

  De, Dibyendu ^a   Nath Sarkar, Rathindra ^a   Phaujdar, Sibaji ^a   Bhattacharyya, Kuntal ^a   Krishna Pal, Hare ^a  

^a MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

CD4 lymphocyte count; HIV; Immune reconstitution inflammatory syndrome; Tuberculosis

Indexed keywords

HYDROCORTISONE;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CERVICAL LYMPHADENOPATHY; CONTROLLED STUDY; COUGHING; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; EXTRAPULMONARY TUBERCULOSIS; FEMALE; FEVER; HEMOPTYSIS; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INCIDENCE; LYMPHADENITIS; MAJOR CLINICAL STUDY; MALE; MILIARY TUBERCULOSIS; MIXED INFECTION; MORTALITY; MULTIPLE ORGAN FAILURE; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION; TUBERCULOSIS; TUBERCULOUS LYMPHADENITIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; ANTITUBERCULAR AGENTS; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INCIDENCE; INDIA; MALE; MIDDLE AGED; RISK FACTORS; TUBERCULOSIS, PULMONARY;

EID: 84855949681     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/S1413-8670(11)70250-1     Document Type: Article

References (17)

1. John M., French M.A. Exacerbation of the inflammatory response to Mycobacterium tuberculosis after antiretroviral therapy. Med J Aust 1998, 169(9):473-474.
2. Antiretroviral Therapy Guidelines for HIV-infected Adults and adolescents including post-exposure prophylaxis by NACO 2007.
3. Murdoch D.M., Venter W.D., Van Rie A., Feldman C. Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther 2007, 4:9.
4. Lawn S.D., Bekker L.G., Miller R.F. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 2005, 5(6):361-373.
5. Sungkanuparph S., Vibhagool A., Mootsikapun P., Chetchotisakd P., Tansuphaswaswadikul S., Bowonwatanuwong C. Opportunistic infections after the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevalence of tuberculosis. AIDS 2003, 17(14):2129-2131.
6. Shankar E.M., Vignesh R., Murugavel K.G., et al. Immune reconstitution inflammatory syndrome in association with HIV/AIDS and tuberculosis: views over hidden possibilities. AIDS Res Ther 2007, 4:29-42.
7. Narita M., Ashkin D., Hollender E.S., Pitchenik A.E. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 1998, 158(1):157-161.
8. Gazzard B. BHIVA Writing Committee. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005). HIV Med 2005, 6(Suppl 2):1-61.
9. Serra F.C., Hadad D., Orofino R.L., et al. Immune reconstitution syndrome in patients treated for HIV and tuberculosis in Rio de Janeiro. Braz J Infect Dis 2007, 11(5):462-465.
10. Shelburne S.A., Visnegarwala F., Darcourt J., et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 2005, 19(4):399-406.
11. Furrer H., Malinverni R. Systemic inflammatory reaction after starting highly active antiretroviral therapy in AIDS patients treated for extrapulmonary tuberculosis. Am J Med 1999, 106(3):371-372.
12. Breton G., Duval X., Estellat C., et al. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin Infect Dis 2004, 39(11):1709-1712.
13. Manosuthi W., Kiertiburanakul S., Phoorisri T., Sungkanuparph S. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy. J Infect 2006, 53(6):357-363.
14. Crump J.A., Tyrer M.J., Lloyd-Owen S.J., Han L.Y., Lipman M.C., Johnson M.A. Military tuberculosis with paradoxical expansion of intracranial tuberculomas complicating human immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy. Clin Infect Dis 1998, 26(4):1008-1009.
15. Wendel K.A., Alwood K.S., Gachuhi R., Chaisson R.E., Bishai W.R., Sterling T.R. Paradoxical worsening of tuberculosis in HIVinfected persons. Chest 2001, 120(1):193-197.
16. Jon F., Tuberculosis Infectious Diseases 2004, 1:401-418. Mosby, Spain.
17. Michailidis C., Pozniak A.L., Mandalia S., Basnayake S., Nelson M.R., Gazzard B.G. Clinical characteristics of IRIS syndrome in patients with HIV and tuberculosis. Antivir Ther 2005, 10(3):417-422.